SubHero Banner
Horizontal Rule

Features and benefits


These surveys gather vital patient-reported outcomes (PRO) data that is useful in identifying patients in need of treatment and assessing treatment effectiveness. They can also assess change in disease control over time in a variety of settings, including disease management and clinical trials.

They can be used alone or paired with an SF™ Health Survey for a more comprehensive measurement of overall health status. These surveys are available in a variety of modes of administration and in numerous language translations.


Horizontal Rule


Accordion Block
  • ACT is a five-question survey used to measure asthma control in individuals 12 years of age and older. The survey measures the elements of asthma control as defined by the National Heart, Lung and Blood Institute (NHLBI).

  • Intended for adults ages 18 and older, the AIS-6 is a six-question survey that measures the impact of asthma on an individual’s functional health and well-being. Specifically, it assesses the impact of asthma in usual daily activities and on social and emotional functioning.

  • The COPD-PS is self-completed and clinically validated for detecting chronic obstructive pulmonary disease (COPD). It is appropriate for use with the general population aged 18 and older. The survey can be used across the health care spectrum from clinical practice to clinical trials.

    It is suitable for use with or without lung-functioning testing. It reflects the full impact of COPD by evaluating various domains, which include:

    • Shortness of breath
    • Cough/sputum
    • Functional impact
    • Other patient characteristics (smoking history, age)


  • HIT-6 is a fixed-length, six-question paper form version of the DYNHA® Headache Impact Test™. It captures the impact of headache and its treatment on an individual's functional health and well-being. It is useful for both screening and monitoring change in headache impact.

  • This two-part survey assesses the functional health and well-being of patients aged 18 and older with chronic hepatitis C. It is designed to help patients and clinicians monitor the effects of hepatitis C and its treatment.

    It includes the SF-36v2 and 15 additional questions that measure other generic health concepts. It is particularly relevant in assessing the impact of hepatitis and disease-specific concepts (for example, hepatitis-specific functional limitations, hepatitis-specific distress).

  • The PMSIS measures the impact of premenstrual symptoms on the functional health and well-being of adult females aged 18 and older. This includes the impact on physical, social and cognitive functioning (for example, concentration).

    Scientifically valid and brief, the PMSIS is practical for use at both the population level and within daily clinical practice. It is used when severe premenstrual symptoms need to be evaluated, monitored and treatment effectiveness determined.

  • The RIS-6 was developed to measure the impact on an individual's functional health and well-being. Specifically, it assesses the impact of rhinitis on everyday performance in usual daily activities, social and emotional functioning, and productivity at work or home.

Solution Tile Component